ESMO Events 2024

Meetings 在新的选项卡/窗口中打开 | ESMO 在新的选项卡/窗口中打开

Welcome to our ESMO Virtual Congress site where we showcase the very best from ESMO's flagship portfolio.

ESMO Asia Congress 2024 在新的选项卡/窗口中打开

The event brings together oncologists, researchers, healthcare professionals, and industry representatives from Asia and around the world.

ESMO Asia 2024 will feature scientific sessions covering a wide range of topics related to oncology, including advances in cancer research, new treatment modalities, and discussions on the management of specific types of cancer.

Its educational sessions will provide in-depth training and insights into specific aspects of oncology, ensuring that participants gain practical knowledge that they can apply in their daily practice.

Below a collection of papers recently published in ESMO’s premier journals carefully selected to reflect the themes of the meeting.

Annals of Oncology

• Survival benefit of adjuvant chemotherapy based on molecular residual disease detection in resected colorectal liver metastases: subgroup analysis from CIRCULATE-Japan GALAXY 在新的选项卡/窗口中打开 K. Kataoka ∙ K. Mori ∙ Y. Nakamura ∙ J. Watanabe ∙ N. Akazawa ∙ K. Hirata ∙ M. Yokota ∙ K. Kato∙ M. Kotaka ∙ K. Yamazaki ∙ Y. Kagawa ∙ S. Mishima ∙ K. Ando ∙ M. Miyo ∙ H. Yukami ∙ G. Laliotis ∙ S. Sharma ∙ C.C. Palsuledesai ∙ M. Rabinowitz ∙ A. Jurdi ∙ M.C. Liu ∙ A. Aleshin ∙ D. Kotani ∙ H. Bando ∙ H. Taniguchi ∙ I. Takemasa ∙ T. Kato ∙ T. Yoshino ∙ E. Oki

• Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): early outcomes of a multicenter randomized phase III trial 在新的选项卡/窗口中打开 Z.Y. Lin^† ∙ P. Zhang^,† ∙ P. Chi^†∙ F.Z. Cheng ∙ K.X. Tao ∙ T. Zhang

ESMO Open

• Global trends in adolescent and young adult female cancer burden, 1990-2021: insights from the Global Burden of Disease study 在新的选项卡/窗口中打开 Z. Huang† ∙ J. Wang,† ∙ H. Liu,† ∙ B. Wang ∙ M. Qi ∙ Z. Lyu ∙ H. Liu

• Survival outcomes of young-age female patients with early breast cancer: an international multicenter cohort study 在新的选项卡/窗口中打开 J. Kim ∙ J. Kim ∙ K.H. Seo ∙ K.-H. Lee ∙ Y.H. Park ∙ C.-H. Lin ∙ Y.-S. Lu ∙ T. Ueno ∙ Y.-S. Yap∙ F.-Y. Wong ∙ V.K.M. Tan ∙ G.-H. Lim ∙ S.-M. Tan∙ W. Yeo ∙ Q. Liu ∙ R. Leung ∙ Y. Naito ∙ H. Li ∙ H.-B. Lee ∙ W. Han ∙ S.-A. Im ∙ Asian Breast Cancer Cooperative Group

Immuno-Oncology and Technology

• Updates in the pathogenesis and management of immune-related enterocolitis, hepatitis and cardiovascular toxicities 在新的选项卡/窗口中打开 J. McKenzie^,† ∙ E. Sneath^,† ∙ A. Trinh ∙ M. Nolan ∙ L. Spain

• Analyzing functional heterogeneity of effector cells for enhanced adoptive cell therapy applications 在新的选项卡/窗口中打开 AC. Kiel Rasmussen† ∙ T.M. Hulen,† ∙ D.L. Petersen,† ∙ M.J. Jacobsen ∙ M.J. Mikkelsen ∙ Ö. Met ∙ M. Donia ∙ C.A. Chamberlain‡,§ christopher.∙ P. Mouritzen,‡

ESMO Gastrointestinal Oncology

• Safety and efficacy of first-line nivolumab plus chemotherapy for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: real-world data analysis 在新的选项卡/窗口中打开 K. Shimozaki ∙ K. Fukuda ∙ A. Ooki ∙ I. Nakayama ∙ K. Yoshino ∙ M. Tamba ∙ S. Udagawa ∙ S. Fukuoka ∙ H. Osumi ∙ T. Wakatsuki ∙ D. Takahari ∙ E. Shinozaki ∙ M. Ogura ∙ K. Chin ∙ K. Yamaguch

• Clinical implementation of simultaneous multiple biomarkers testing for metastatic or recurrent gastroesophageal adenocarcinoma: a single-institutional experience 在新的选项卡/窗口中打开 U. Okazaki ∙ I. Nakayama o.jp ∙ N. Sakamoto ∙ T. Kuwata ∙ A. Kawazoe ∙ M. Yoshida ∙ M. Yura ∙ Y. Matsubara ∙ A. Jubashi ∙ S. Sato ∙ S. Ushiyama ∙ Y. Miyashita ∙ A. Kobayashi ∙ T. Hashimoto ∙ S. Mishima ∙ D. Kotani ∙ Y. Nakamura ∙ Y. Kuboki ∙ H. Bando ∙ T. Kojima ∙ T. Yoshino ∙ T. Kinoshita ∙K. Shitara

ESMO Real World Data and Digital Oncology

• Clinical trial and real-world evidence of circulating tumor DNA monitoring to predict recurrence in patients with resected colorectal cancer 在新的选项卡/窗口中打开 H.T. Nguyen,† ∙ V.-A. Nguyen Hoang† ∙ T.V. Nguyen,† ∙ N.A.L. Trinh ∙ T.H. Pham ∙ D.N. Le ∙ H.H. Ho ∙ T.D. Nguyen ∙ H.D. Nguyen ∙ T.S.L. Thi

• Cancer registry as external control data for regulatory submission in Japan 在新的选项卡/窗口中打开 H. Bando† ∙ N. Okita,† ∙ Y. Sakamoto ∙ H. Sokuoka ∙ Y. Nakamura ∙ T. Hashimoto ∙ T. Misumi ∙ Y. Takeda ∙ Y. Aoyagi ∙ K. Mizuguchi ∙ H.S. Okuma ∙ N. Fuse ∙ K. Yonemori ∙ K. Nakamura ∙ N. Yamamoto ∙ T. Yoshino ∙ A. Ohtsu

ESMO affiliated journals

• Financial toxicity, family resilience and negative emotions among young and middle-aged breast cancer patients: A multicentre cross-sectional study 在新的选项卡/窗口中打开 Xuelei Chena, ∙ Qilin Yanc,∙ Youjuan Tangb, ∙ Jianing Zhud, ∙ Wenlu Zhanga, ∙ Jingping Zhanga

• 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7) 在新的选项卡/窗口中打开 Fatima Cardosoa ∙ Shani Paluch-Shimonb ∙ Eva Schumacher-Wulfc ∙ Leonor Matosd ∙ Karen Gelmone ∙ Matti S. Aaprof ∙ Jyoti Bajpaig ∙ Carlos H. Barriosh ∙ Jonas Berghi ∙ Elizabeth Bergsten-Nordströmj ∙ Laura Biganzolik ∙ Maria João Cardosol ∙ Lisa A. Careym ∙ Mariana Chavez-MacGregorn ∙ Runcie Chidebeo ∙ Javier Cortésp ∙ Giuseppe Curiglianoq,r ∙ Rebecca A. Dents ∙ Nagi S. El Saghirt ∙ Alexandru Eniuu ∙ Lesley Fallowfieldv ∙ Prudence A. Francisw ∙ Sandra X. Franco Millanx ∙ Jenny Gilchristy ∙ Joseph Gligorovz ∙ William J. . Gradisharaa ∙ Renate Haidingerab ∙ Nadia Harbeckac ∙ Xichun Huad ∙ Ranjit Kaurae ∙ Belinda Kielyaf ∙ Sung-Bae Kimag ∙ Smruti Koppikarah ∙ Marion J.J. Kuper-Hommelai ∙ Frédéric E. Lecouvetaj ∙ Ginny Masonak ∙ Shirley A. Mertzal ∙ Volkmar Muelleram ∙ Claire Myersonan ∙ Silvia Neciosupao ∙ Birgitte V. Offersenap ∙ Shinji Ohnoaq ∙ Olivia Paganiar ∙ Ann H. Partridgeas ∙ Frédérique Penault-Llorcaat ∙ Aleix Pratau ∙ Hope S. Rugoav ∙ Elzbieta Senkusaw ∙ George W. Sledgeax ∙ Sandra M. Swainay ∙ Christoph Thomssenaz ∙ Daniel A. Vorobiofba ∙ Peter Vuylstekebb ∙ Theresa Wisemanbc ∙ Binghe Xubd ∙ Alberto Costabe ∙ Larry Nortonbf ∙ Eric P. Winer

• Evolving immunotherapeutic solutions for triple-negative breast carcinoma 在新的选项卡/窗口中打开 Shiting Wu ∙ Anqi Ge ∙ Xianguang Deng ∙ Lifang Liu ∙ Yue Wang

• Bone complications of cancer treatment 在新的选项卡/窗口中打开 Nanxi Zhu ∙ Hao Ni ∙ Shengzhao Guo ∙ Ying-Qiang Shen ∙ Qianming Chen

• Risk of Secondary Malignancies After Multiple Myeloma: A Nationwide Case-Control Cohort Study 在新的选项卡/窗口中打开 Heejoo Ko ∙ Sung-Soo Park ∙ Suein Choi ∙ Ja Min Byun∙ Chang-Ki Min

• Second Treatment-Free Remission Attempt in Patients with Chronic Myeloid Leukemia 在新的选项卡/窗口中打开 Hiroshi Ureshino ∙ Kazuharu Kamachi ∙ Shinya Kimura

ESMO's Journal Portfolio

While diverse in nature and in content, these journals offer ESMO members and the oncology community a highly visible platform to publish important scientific studies, and a highly credible source for educational updates. Elsevier is the proud publisher of Annals of Oncology, Immuno-Oncology and Technology (IOTECH), ESMO Open, ESMO Gastrointestinal Oncology, ESMO Real World Data and Digital Oncology, and ESMO Affiliated Journals The Breast, Lung Cancer, Cancer Treatment Reviews and Clinical Lymphoma Myeloma and Leukemia.